All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
CAR-T therapy has emerged as a groundbreaking approach in the immunotherapy landscape. Given the complexity and specificity of CAR-T therapy, the production of high-quality materials such as in vitro transcribed RNA (IVT RNA) is crucial. IVT RNA plays an essential role in delivering genetic information into T cells, facilitating the expression of CARs. At Creative Biolabs, we are committed to providing top-tier IVT RNA manufacturing services specifically optimized for CAR-T applications. Our advanced platform ensures precision and efficiency, supporting researchers and clinicians in the development and deployment of cutting-edge CAR-T therapies.
At Creative Biolabs, our IVT RNA platform is meticulously designed to meet the diverse needs of researchers and clinicians in developing of CAR-T therapy. This platform integrates state-of-the-art technologies and stringent quality control measures to ensure the production of high-fidelity mRNA transcripts, which are crucial for effective CAR-T cell engineering. Utilizing a comprehensive IVT RNA platform, our experts proudly provide high-quality mRNA tailored for research purposes, ensuring that the initial stages of CAR-T and other advanced therapies are founded on reliable and effective mRNA constructs. By employing our RG mRNA manufacturing platform, researchers can confidently advance their CAR-T studies, armed with the assurance that their mRNA constructs are of the highest quality.
At Creative Biolabs, we are committed to advancing the field of CAR-T therapy through our specialized IVT RNA and LNP manufacturing services. Our robust RG mRNA manufacturing platform combines scalability, high purity, customization, advanced quality control, and efficient delivery systems to meet the diverse needs of CAR-T researchers. By partnering with us, you gain access to cutting-edge technologies and expert support, empowering you to drive innovation and make significant strides in the fight against cancer.
For any technical issues or product/service related questions, please leave your information below. Our team will contact you soon.
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION